AwesomeCapital
Search This Blog
Tuesday, June 11, 2019
Kindred Biosciences started at Overweight by Barclays
Target $13
https://www.benzinga.com/stock/KIN/ratings
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.